Filing Details

Accession Number:
0001562180-17-002011
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-19 11:27:06
Reporting Period:
2017-05-17
Filing Date:
2017-05-19
Accepted Time:
2017-05-19 11:27:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1395937 Syndax Pharmaceuticals Inc SNDX Pharmaceutical Preparations (2834) 320162505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594274 Peter Ordentlich C/O Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive, Building D, Floor 3
Waltham MA 02451
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-17 732 $3.08 5,000 No 4 M Direct
Common Stock Disposition 2017-05-17 5,000 $15.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2017-05-17 732 $0.00 732 $3.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-09 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  2. The option is fully vested.